SCHEMBL20610863

SCHEMBL20610863

COc1cc(OC)c(Cl)c(N(COCC[Si](C)(C)C)CN(C)c2cc(Cl)ncn2)c1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16654119 0.79 FGFR3 (0.35) —
SCHEMBL16654403 0.75 FGFR4 (0.41) —
SCHEMBL16665253 0.74 FGFR1 (0.33) —
SCHEMBL16655847 0.72 FGFR4 (0.42) —
SCHEMBL16655790 0.70 FGFR1 (0.44) —
SCHEMBL22157649 0.70 FGFR4 (0.32) —
SCHEMBL16659627 0.68 FGFR3 (0.33) —
SCHEMBL28767434 0.68 FGFR1 (0.33) —
SCHEMBL28767438 0.67 FGFR3 (0.42) —
SCHEMBL28768907 0.66 FGFR3 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3421457-B1 PYRIMIDINE FGFR4 INHIBITORS EISAI R&D MAN CO LTD (JP) 2021-10-06 — — EP disclosed
EP-3421457-A1 PYRIMIDINE FGFR4 INHIBITORS Eisai R&D Management Co., Ltd. (JP) 2019-01-02 — — EP disclosed
Send feedback